AG
CLB icon

Advisor Group’s Core Laboratories CLB Stock Holding History

Advisor Group’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$107K Sell
2,857
-320
-10% -$14.4K ﹤0.01% 2891
2019
Q3 		$148K Sell
3,177
-66
-2% -$3.07K ﹤0.01% 2560
2019
Q2 		$170K Sell
3,243
-8,636
-73% -$507K ﹤0.01% 2438
2019
Q1 		$820K Sell
11,879
-1,002
-8% -$67.2K 0.01% 1225
2018
Q4 		$769K Buy
12,881
+115
+0.9% +$9.92K 0.01% 1116
2018
Q3 		$1.48M Buy
12,766
+2,815
+28% +$318K 0.01% 786
2018
Q2 		$1.26M Sell
9,951
-422
-4% -$51.4K 0.02% 750
2018
Q1 		$1.12M Buy
10,373
+69
+0.7% +$7.64K 0.02% 800
2017
Q4 		$1.13M Buy
10,304
+605
+6% +$60.4K 0.02% 813
2017
Q3 		$958K Buy
9,699
+1,282
+15% +$124K 0.02% 823
2017
Q2 		$852K Buy
8,417
+1,998
+31% +$215K 0.02% 834
2017
Q1 		$742K Buy
6,419
+5
+0.1% +$581 0.02% 868
2016
Q4 		$769K Sell
6,414
-327
-5% -$36.2K 0.02% 774
2016
Q3 		$758K Sell
6,741
-1,245
-16% -$143K 0.02% 760
2016
Q2 		$987K Buy
+7,986
New +$964K 0.03% 623

Other funds holding CLB

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

Advisor Group's CLB Position: Q4 2019 in Review

Advisor Group reduced its Core Laboratories (CLB) stake by 10% in Q4 2019, selling an estimated $14.4K and leaving 2,857 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #2891.

Advisor Group first reported a position in CLB in Q2 2016 and has held it in 15 quarters since. The position peaked at $1.48M in Q3 2018. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

  • Advisor Group held 2,857 shares of Core Laboratories worth $107K as of Q4 2019.
  • Advisor Group sold 320 Core Laboratories shares in Q4 2019, an estimated $14.4K.
  • Core Laboratories made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2891 holding.
  • Advisor Group first reported a position in Core Laboratories in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Core Laboratories position peaked at $1.48M in Q3 2018.
  • 283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.